Answers are grounded in this paper and cite their sources.
The relationship between mitophagy, a selective form of macroautophagy/autophagy that targets dysfunctional or excessive amounts of irregular mitochondria for degradation, and mycophagy, a selective autophagy mechanism for the removal of dysfunctional/unwanted lysosomes, in the context of intervertebral disc degeneration (IVDD) has not been sufficiently elucidated.This study was conducted to investigate the question, "Can IVDD be delayed or halted through pharmacological targeting of mitophagic or dysphagic signaling pathways?".For this purpose, systematic searches were conducted in the PubMed electronic database without country or language restrictions until March 21, 2024, using sequential searches with keywords related to the topic using "and/or" combinations to select high-evidence studies.Findings from studies meeting the research criteria and undergoing full-text assessment were compiled into an Excel spreadsheet using Microsoft Office.Results are presented in counts and/or frequencies (%).Following a comprehensive literature search, 12.720 studies were encountered, with 11.49% being reviewed.Although no clinical research related to the topic was found, no studies fully encompassed the inclusion criteria or the keywords "mitophagy"/"lysophagy" with "IVDD".Based on the existing literature, it is impossible to determine the level of evidence regarding the effect of mitophagic and/or dysphagic signaling pathways on IVDD or to discuss the effectiveness and reliability of targeting these pathways in treating degeneration.To establish evidence-based conclusions on this research topic, findings from multicenter, double-blind, randomized, and clinical trials involving a larger number of cases in different populations need to be evaluated.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: